Blog ASCO 2015: What to Watch in Immunotherapy May 28, 2015December 14, 2022 Jill O'Donnell-Tormey, PhD
Blog FDA-Approved Cancer Immunotherapies and CRI’s Impact April 9, 2015December 14, 2022 Alexandra Mulvey
Blog Merck’s PD-1 Drug Outperforms Ipilimumab for Treatment of Advanced Melanoma March 24, 2015December 14, 2022 Matthew Tontonoz
Blog What Cancer Patients Need to Know About the Opdivo Approval March 13, 2015December 14, 2022 Emily Helck
Blog Big News: FDA Approves Opdivo (Nivolumab) for Lung Cancer March 4, 2015December 14, 2022 Matthew Tontonoz